NPC at ISPOR 2024
The NPC team is heading to ISPOR 2024 to present research findings and to examine complex topics in pricing and value assessment. Will you be there? If so, let us know!
NPC Heads to ISPOR 2024
The National Pharmaceutical Council research team will participate in the upcoming ISPOR 2024 conference to be held in Atlanta, May 5-8, 2024. Check out the information below about the events and sessions featuring NPC's researchers.
View the full conference program on the ISPOR 2024 webpage.
Monday, May 6
POSTER SESSIONS
Session: 10:30 a.m. – 1:30 p.m. | Discussion: 12:30 p.m. – 1:30 p.m.
- A Preliminary Assessment of ICER's New HTA Methods That Support Health Equity
Presenter: Tamara Brisbane, PharmD, Cencora
Co-author: Kimberly Westrich, MA, National Pharmaceutical Council
- Variation in Per Beneficiary Prescription Utilization by Race/Ethnicity in Medicare and Medicaid Insurance Claims
Presenter: Tyler D. Wagner, PharmD, PhD, National Pharmaceutical Council
- Payer Perspectives on the Use of ICER Evidence Reports Over the Past 24 Months
Presenter: Victoria Loo, MPH, Cencora
Co-author: Kimberly Westrich, MA, National Pharmaceutical Council - Revenue-Sharing or Revenue Lost? The Hidden Costs of 340B to Employers
Presenter: James Motyka, PharmD, National Pharmaceutical Council
ISPOR STUDENT NETWORK ROUNDTABLE: Unpacking the Inflation Reduction Act (IRA) – Status and Implications Beyond Drug Pricing
1:30 p.m. – 2:30 p.m.
The ISPOR Student Network Roundtable Event will discuss the Inflation Reduction Act (IRA), with an overview of the status, next steps, and longer-term implications, as well as a focus on the aspects of the IRA beyond the drug-pricing related components. The talk will explore how the IRA impacts access, affordability, and sustainability in health care and implications in healthcare policy decision making.
The talk will be presented by a panel of experts to discuss the IRA from the industry, independent, and academic perspective. The speakers will engage in a discussion both with each other and with the audience through a question-and-answer format. This talk will educate not only students and new professionals, but also all other members of ISPOR attending the conference interested in the impact of the IRA.
Moderator:
- Jordan Skiera, PharmD/MSL Candidate, McWhorter School of Pharmacy, Samford University
Speakers:
-
Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson
-
Joey Mattingly, Associate Professor and Vice Chair of Research, Department of Pharmacotherapy University of Utah College of Pharmacy
-
Julie Patterson, Senior Director of Research, National Pharmaceutical Council
-
Peter Neumann, Director and Professor, Center for the Evaluation of Value and Risk in Health at the Institute Clinical Research and Health Policy Studies, Tufts University School of Medicine
NPC-SPONSORED STUDENT RECEPTION
2:45 p.m.
NPC is proud to sponsor the Student Reception following the Student Network Roundtable.
EDUCATIONAL SYMPOSIUM: Staying Ahead of the Curve: Navigating Policy Changes and Ensuring Patient Access in the Era of IRA and EU HTA
3:15 p.m. – 4:15 p.m.
Moderator:
- Corey Ford, MHA, Cencora
Panelists:
- Michael Drummond, PhD, University of York
- Casper Paardekooper, MSc, Vintura, part of Cencora
- Kimberly Westrich, MA, National Pharmaceutical Council
POSTER SESSION
Session: 3:30 p.m. – 6:30 p.m. | Discussion: 4:00 p.m. – 5:00 p.m.
- Mapping Medicaid: A Comparative Analysis of State-Level Racial and Ethnic Data Collection to Federal Guidelines
Presenter: Rayan Salih, PharmD, National Pharmaceutical Council
Tuesday, May 7
CONCURRENT BREAKOUT SESSION: "Whole Health” Value Assessment – Universal Survey Framework for Integrating Patient Experience Data in Health Technology Assessment
1:45 p.m. – 2:45 p.m.
Moderator:
- Kimberly Westrich, MA, National Pharmaceutical Council
Panelists:
- Kayleigh Majercak, MS, Dept. Pharmaceutical Health Services Research, University of Maryland School of Pharmacy
- Robert Brett McQueen, PhD, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado
- Joe Vandigo, MBA, PhD, Applied Patient Experience, LLC
PODIUM PRESENTATION: Unsupported Policy Information? The Institute for Clinical and Economic Review's Unsupported Price Increase Reports
2:30 p.m. – 2:45 p.m.
Presenter: Jane Ha, PharmD, MS, Cencora
Co-author: Kimberly Westrich, MA, National Pharmaceutical Council
POSTER SESSION
Session: 3:30 p.m. – 6:30 p.m. | Discussion: 4:00 p.m. – 5:00 p.m.
- Breadth of Patient and Stakeholder Input in CMS's Drug Price Negotiation Program: A Content Analysis of the 2023 Patient-Focused Listening Sessions
Presenter: Julie Patterson, PharmD, PhD, National Pharmaceutical Council
Co-authors: Tyler D. Wagner, PharmD, PhD, National Pharmaceutical Council, Rayan Salih, PharmD, National Pharmaceutical Council, Gabri'el Shabazz, MPH, National Pharmaceutical Council, Jonathan D. Campbell, PhD, National Pharmaceutical Council
Wednesday, May 8
POSTER SESSIONS
Session: 10:30 a.m. – 1:30 p.m. | Discussion: 12:30 p.m. – 1:30 p.m.
- Better Late Than Never? Payer Appetite and Vision for a National Value Assessment Body
Presenter: Leann Baker, Cencora
Co-author: Kimberly Westrich, MA, National Pharmaceutical Council
- Employer Perspectives on Alternative Funding Programs
Presenter: James Motyka
Co-author: Kimberly Westrich, MA, National Pharmaceutical Council - Beyond the Headline: Inflation-Adjusting ICER’S Unsupported Price Increase Results
Presenter: Tyler D. Wagner, PharmD, PhD, National Pharmaceutical Council
Co-authors: Kimberly Westrich, MA, National Pharmaceutical Council, Robert J. Nordyke, PhD, MS, National Pharmaceutical Council, Jonathan D. Campbell, PhD, National Pharmaceutical Council
PODIUM PRESENTATION: Payer Willingness to Pay for Novel Value Attributes – The Impact of Higher WTP Thresholds on ICER’s Cost Effectiveness Determinations
Wednesday, May 8 | 10:00 a.m. – 10:15 a.m.
Presenter: Ben Penley, Cencora
Co-author: Kimberly Westrich, MA, National Pharmaceutical Council